Free shipping on all orders over $ 500

Lonafarnib

Cat. No. M2307
Lonafarnib Structure
Synonym:

SCH66336

Size Price Availability Quantity
10mM*1mL in DMSO USD 165  USD165 In stock
2mg USD 90  USD90 In stock
5mg USD 115  USD115 In stock
10mg USD 185  USD185 In stock
25mg USD 370  USD370 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Lonafarnib (SCH 66336) is a selectively farnesyl protein transferase (FPT) inhibitor, inhibiting H-ras, K-ras-4B and N-ras with IC50 of 1.9 nM, 5.2 nM and 2.8 nM, respectively. Lonafarnib (8 μM) suppresses PKB/Akt activity as well as the phosphorylation of the Akt substrates glycogen synthase kinase (GSK)-3β, forkhead transcription factor, and BAD in SqCC/Y1 cells. Lonafarnib induces a CCAAT/enhancer-binding protein homologous protein (CHOP)-dependent transactivation of the DR5 promoter, thus induces CHOP-dependent DR5 up-regulation.

Chemical Information
Molecular Weight 638.82
Formula C27H31Br2ClN4O2
CAS Number 193275-84-2
Solubility (25°C) DMSO 50 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] Tingting Chen, et al. Front Pharmacol . Farnesyl Transferase Inhibitor Lonafarnib Enhances α7nAChR Expression Through Inhibiting DNA Methylation of CHRNA7 and Increases α7nAChR Membrane Trafficking

[2] Leslie B Gordon, et al. Association of Lonafarnib Treatment vs No Treatment With Mortality Rate in Patients With Hutchinson-Gilford Progeria Syndrome

[3] Nan Soon Wong, et al. Lonafarnib for cancer and progeria

[4] Deviney Chaponis, et al. J Neurooncol . Lonafarnib (SCH66336) improves the activity of temozolomide and radiation for orthotopic malignant gliomas

[5] M Liu, et al. Cancer Res . Antitumor activity of SCH 66336, an orally bioavailable tricyclic inhibitor of farnesyl protein transferase, in human tumor xenograft models and wap-ras transgenic mice

Related Transferase Products
POP-3MB

POP-3MB is an ICMT inhibitor (IC50: 2.5 μM).

P61A6

P61A6, a dihydropyrrole ring derivative and also a GGTase-I inhibitor, effectively inhibited tumor cell proliferation in a non-small cell lung cancer xenograft model, with IC50 values of 5-15 μmol/L for H358, H23 and H1507 cells.

Glabrol

Glabrol is a potent and non-competitive Acyl-coenzyme A: cholesterol acyltransferase (ACAT) inhibitor with an IC50 value of 24.6 μM for rat liver microsomal ACAT activity.

3-Oxopomolic acid

Pomonic acid is a triterpenoid that significantly inhibits cholesterol ester accumulation and suppresses the acyl coenzyme A:cholesterol acyltransferase (ACAT) activity.

GST-IN-1

GST-IN-1 is a glutathione S-transferase (GST) inhibitor with IC50s of 1.55 μM (sjGST) and 2.02 μM (hGSTM2), respectively.

  Catalog
Abmole Inhibitor Catalog




Keywords: Lonafarnib, SCH66336 supplier, Transferase, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.